Skip to content

Seminar Title

 

Synergy Satellite: Targeted drugs – scattered goals (sponsored by a grant from Novartis)

Affiliation

German Cancer Research Center & University Hospital Heidelberg

Country

Germany

1. Current Status, Position

  • Head of Division, CCU Pediatric Oncology, DKFZ Heidelberg;
  • Head of Division, Pediatric Brain Tumors, University Hospital Heidelberg.

2. Education

  • Training in Pediatrics, Pediatric Oncology and Neonatal Medicine at University of Göttingen Medical School;
  • Postdoctoral Fellow in Molecular Biology of Histone Family Variants in Cancer at University of Göttingen;
  • W3 joined professorship at DKFZ/University Hospital Heidelberg and Head of Division CCU Pediatric Oncology since 2005.

3. Research Area

  • Clinical Specialization in Pediatric Neurooncology;
  • Interest in Personalized Pediatric Oncology, novel targeted treatment approaches, clinical translation of novel targets based on mechanism of action;
  • Evaluation of individual members of histone deacetylase family as selective drug targets and their mechanism of action.

Conflict of interest: Consultant for Astra Zeneca and Novartis and Research Grant Recipient from Bayer Healthcare.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.